Abstract:1666 Objectives: Dementia with Lewy bodies (DLB) shares many similar aspects with Parkinson’s disease dementia (PDD) and Alzheimer’s disease (AD). Distinction between these diseases becomes important from the viewpoint of clinical treatment and pharmacological trials. Previous MRI studies indicated that the brain network organizations of these diseases are different1,2. In this study, we investigated the difference of the topological architecture of whole-brain connectivity in different dementias by using 18F-FDG PET imaging. Methods: Twenty-two patients with clinically probable DLB, eighteen probable PDD, twenty-two probable AD and twenty-two healthy controls (HC) were recruited to perform 18F-FDG PET imaging in resting state. It is assumed that brain regions whose cerebral metabolic rate for glucose (CMRgl) values are significantly correlated are functionally associated and the local CMRgl in a set of 90 structures belonging to the AAL atlas was obtained. The glucose metabolism network (represented by the matrix of the CMRgl covariations among all pairs of structures) was studied using the graph theory framework. Results: The highest concurrent fluctuations in CMRgl were basically identified between homologous cortical regions in all groups. Compared to the HC group, the small world characteristics of the three dementia groups was damaged, where the DLB group was most severely, the AD group followed, and the PDD group was most lightly. In term of global and local network properties, the clustering coefficients of three dementia groups were higher, the characteristic path lengths were longer and the local efficiency and global efficiency were at the lowest level in the DLB group. A direct comparison between with and without regression found that gender and age had significant effects on the brain networks. Conclusions: This study is an attempt at exploring the complex metabolic connectivity dysfunction in DLB and suggests the potential of using network topology as a diagnostic biomarker. References: 1. Peraza LR, et al. Divergent brain functional network alterations in dementia with Lewy bodies and Alzheimer’s disease. Neurobiol Aging 2015; 36:2458-2467 2. Borroni B, et al. Structural and functional imaging study in dementia with Lewy bodies and Parkinson9s disease dementia. Parkinsonism Relat Disord 2015; 21:1049-1055 Research support: The study was supported by grants (No.81771483, No. 81671239, No. 81401135 and No. 81361120393) from the National Natural Science Foundation of China.

Comparison of Cerebral ECD Perfusion in Patients with Dementia with Lewy Bodies and Parkinson′s Disease Dementia

Consistent Abnormalities in Metabolic Patterns of Lewy Body Dementias

Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia

Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson'S Disease

Proton Magnetic Resonance Spectroscopy Detects A Relative Decrease of N-Acetylaspartate in the Hippocampus of Patients with Dementia with Lewy Bodies

Disrupted Network Topology in Dementia with Lewy Bodies and Comparision with Alzheimer's Disease and Parkinson's Disease Dementia

Glucose Metabolic Brain Network Differences Between Chinese Patients with Lewy Body Dementia and Healthy Control

Noninvasive neuroimaging provides evidence for deterioration of the glymphatic system in Parkinson's disease relative to essential tremor

Intracerebral hemodynamic abnormalities in patients with Parkinson's disease: Comparison between multi-delay arterial spin labelling and conventional single-delay arterial spin labelling

Validation of the cingulate island sign with optimized ratios for discriminating dementia with Lewy bodies from Alzheimer's disease using brain perfusion SPECT

Discriminative pattern of reduced cerebral blood flow in Parkinson’s disease and Parkinsonism-Plus syndrome: an ASL-MRI study

[Clinical and neuropsychological features and changes to regional cerebral blood flow in ‍patients with Parkinson's disease dementia]

Clinical application of brain perfusion SPECT/CT imaging with NeuroGamTM software in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease

Distinct Cerebral Small Vessel Disease Impairment in Early- and Late-Onset Alzheimer's Disease.

Distinct Patterns of Interhemispheric Connectivity in Patients with Early- and Late-Onset Alzheimer’s Disease

Brain perfusion SPECT in dementia: what radiologists should know

Quantifying cerebral blood flow changes using arterial spin labeling: A comparative study of idiopathic rapid eye movement sleep behavior disorder and Parkinson's disease

99m Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder

Hypoperfusion in Alzheimer's Disease–Prone Regions and Dementia Conversion in Parkinson's Disease

Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study

Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders